Yew Bio Pharm Cash Flow - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.28 $0 (0%) YEWB stock closing price Mar 29, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Yew Bio Pharm needs to disclose. The profit-loss statement shows Yew Bio Pharm profits, the balance sheet shows Yew Bio Pharm debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Yew Bio Pharm stock analysis shows positive net income cash flow of $3.43M for 2016-Q3. This statement is important because profits alone cannot pay employees, or bills. Cash is required.   Yew Bio Pharm had an inflow of $0.14M from operating activities, $0.01M spend due to financing activities, and $0.01M spend due to investing activities for 2016-Q3. View details of Yew Bio Pharm cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Yew Bio Pharm Net Income Cash Flow
3.43M2.35M1.05M5.28M3.89M2.96M0.95M4.28M3.68M2.79M
Depreciation Depletion Amortization Cash-Flow8.87M8.87M5.02M7.74M1.22M0.33M0.16M0.68M0.51M0.34M
Net Increase (Decrease) in Assets Liabilities-12.19M-11.16M-6.57M-15.43M-7.09M-5.41M-1.78M-1.35M-1.03M-0.28M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.24M0.16M0.08M1.03M0.77M0.55M0.3M0.5M0.32M-
Yew Bio Pharm Net Cash from (used by) Operating Activities
0.36M0.22M-0.41M-1.37M-1.2M-1.57M-0.35M4.11M3.49M2.85M
Increase (Decrease) in Prop Plant And Equipment-0.01M---0.02M-1.37M-0.59M---4.5M-3.75M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----2.33M----2.44M--
Yew Bio Pharm Net Cash from (used by) Invesment Activities
-0.01M---2.36M-1.37M-0.59M--2.44M-4.5M-3.75M
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings---3.21M1.64M1.64M----
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.04M-0.03M-0.02M0.74M0.65M0.65M--2.33M-0.02M-0.02M
Yew Bio Pharm Net Cash from (used by) Financing Activities
-0.04M-0.03M-0.02M3.96M2.29M2.29M--2.33M-0.02M-0.02M
Effect of Exchange Rate Changes on Cash-0.02M-0.01M--0.03M-0.03M---0.01M-0.01M-0.01M
Yew Bio Pharm Net Change in Cash & Cash Equivalents
0.28M0.16M-0.44M0.19M-0.31M0.12M-0.35M-0.67M-1.03M-0.92M
Cash & Equivalents at Beginning of Year0.48M1.15M0.38M0.73M1.85M-----
Cash & Equivalents at Year End0.96M0.84M0.23M0.68M0.17M0.61M0.12M0.48M0.12M0.23M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Yew Bio Pharm stock price history and Yew Bio Pharm stock comparison chart inevitably reflect its cash flow situation.
  • Net Change in Cash and Cash Equivalents: Yew Bio Pharm cash grew QoQ to $3.43M, meaning the company is able to meet its expenditure and grow cash which will also eventually reflect in the Yew Bio Pharm stock price movement.
  • Cash Flow from operating activities: Yew Bio Pharm reported a positive operating cash flow of $0.36M for 2016-Q3 and has seen an increase from the previous quarter. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc. , and was $0.36M for YEWB in last quarter report.
  • Cash flow from financing activities shows the flow of cash between Yew Bio Pharm and its owners and creditors and was $-0.04M for 2016-Q3. Financing activities allow a company to raise capital, and repay bondholders.
.